Zaizen, Yoshiaki
Okamoto, Masaki
Azuma, Koichi
Fukuoka, Junya
Hozumi, Hironao
Sakamoto, Noriho
Suda, Takafumi
Mukae, Hiroshi
Hoshino, Tomoaki
Funding for this research was provided by:
Kaken Pharmaceutical (19K08637)
Article History
Received: 17 November 2022
Accepted: 8 February 2023
First Online: 19 March 2023
Declarations
:
: This study was conducted in accordance with the tenets of the Declaration of Helsinki and approved by the Institutional Review Board of our institute (approval date, July 31, 2019, No. 19090). All procedures were approved by the Committee on the Ethics of Animal Experiments, Kurume University (Approval No. 2022-083, 2022-084, 2022-085). Animal care was provided in accordance with the procedures outlined in the “Principles of laboratory animal care” (National Institutes of Health Publication 86-23, revised 1985). All efforts were made to minimize the suffering of animals used in this study. Informed consent was obtained from all the patients or the surviving family members in the form of opt-out methodology.
: Not applicable.
: The authors declare that no potential conflicts of interest exist with any company/organization whose products or services are discussed in this article.